Exercise Promotion for Breast Cancer Survivors
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are taking mood stabilizing medications like antipsychotics, anticonvulsants, or lithium, you may not be eligible to participate.
What data supports the effectiveness of the treatment Core Exercise Promotion Intervention for breast cancer survivors?
Research shows that physical activity provides numerous health benefits for cancer survivors, improving both patient-reported outcomes and physiological health during and after cancer therapy. Additionally, a motivational program for women after breast cancer has been shown to increase physical activity levels 12 months post-rehabilitation.12345
Is the exercise promotion intervention safe for breast cancer survivors?
How does the Core Exercise Promotion Intervention treatment differ from other treatments for breast cancer survivors?
The Core Exercise Promotion Intervention is unique because it focuses on promoting physical activity among breast cancer survivors, using behavior change techniques to improve exercise adherence and health outcomes. Unlike standard treatments that may focus on medication or surgery, this intervention aims to enhance physical activity through structured programs and support, potentially improving overall well-being and reducing fatigue.2461112
What is the purpose of this trial?
The goal of this clinical trial is to test the effect of an affect-based exercise prescription on moderate-vigorous physical activity participation among survivors of breast cancer who completed primary treatment within the last 5 years. The main questions it aims to answer are:1. Do at least 50% of participants assigned to the affect-based exercise prescription engage in ≥90 minutes of moderate-vigorous physical activity by the end of 12-weeks follow-up?2. What level of satisfaction do breast cancer survivors who receive the affect-based exercise prescription report relative to breast cancer survivors who receive an effort-based exercise prescription.3. What proportion of participants assigned to the affect-based exercise prescription stay enrolled in the study relative to the number of participants who stay enrolled in the effort-based exercise prescription.All participants will:* Be assigned to either the Affect-based exercise prescription or the Effort-based exercise prescription.* Participate in two meetings with a member of the study team meant to help them get started increasing weekly exercise. These meetings are the same for all participants.* Be asked to wear an activity monitor and respond to brief surveys for 10 straight days at 4 points in time: Baseline, 2weeks, 6weeks, and 12weeks.
Research Team
Courtney Stevens, PhD
Principal Investigator
Dartmouth-Hitcock Health
Eligibility Criteria
This trial is for breast cancer survivors who finished their primary treatment within the last 5 years. Participants should be interested in increasing physical activity and willing to wear an activity monitor and answer surveys at specified times.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants are assigned to either the Affect-based or Effort-based exercise prescription and participate in initial meetings to increase weekly exercise
Exercise Intervention
Participants follow their assigned exercise prescription and wear an activity monitor, responding to surveys at specified intervals
Follow-up
Participants are monitored for changes in physical activity, depressive symptoms, and other health measures
Treatment Details
Interventions
- Core Exercise Promotion Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dartmouth-Hitchcock Medical Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator